NCT07863219Recruiting
Short Term Effects of a Multimodal Intervention With RGM on Cognition in People With Parkinson's Disease.
Short-term Effects of an Intervention Consisting of 10 RGM (Ronnie Gardiner Method) Training Sessions on Cognitive Functions in Individuals With Early- to Mid-stage Parkinson's Disease.
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn if the Ronnie Gardiner Method (RGM) works to improve cognitive functions in adults with Parkinson's disease (early to mid-stage). It will also learn about the secondary effects on speech, mobility, balance, and mood. The main questions it aims to answer are: * Does a 10-week RGM intervention improve cognitive aspects, speech (indirectly through improved breathing), mobility, and balance in participants with Parkinson's disease? * How do participants experience the intensity, difficulty, and emotional impact of the RGM sessions?
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 9 Sept 2026
- Start date
- Aug 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- University Ghent
- Diseases
- Parkinson disease
- NCT number
- NCT07863219
What you commit to
- Study type: Interventional
- Planned participants: 20
- From Aug 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of other neurological or severe psychiatric conditions that could interfere with participation or the interpretation of results (e.g., substance use disorder, severe depression, psychosis)
Other
- Severe visual or hearing impairments that limit the ability to follow group instructions as determined by a physician.
- Physical limitations that inhibit safe participation in moderate-to-vigorous exercise or group rehabilitation.
Who the study is looking for
- diagnosis of idiopathic Parkinson's disease
- safe, independent mobility and participation (Hoehn and Yahr stages 1-3)
- a stable dopaminergic medication regimen for at least 4 weeks prior to study participation
- willingness and ability to participate in a 10-week intervention program
- willingness to participate in the study (signing of informed consent)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Ghent Coordinator of this site? Confirm its status | Ghent | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.